Your browser doesn't support javascript.
loading
Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction.
Ho, William Y; Blattman, Joseph N; Dossett, Michelle L; Yee, Cassian; Greenberg, Philip D.
Affiliation
  • Ho WY; Program in Immunology, Clinical Research Division, Fred Hutchinson Cancer Research Center and the University of Washington, Department of Medicine, Seattle, USA.
Cancer Cell ; 3(5): 431-7, 2003 May.
Article in En | MEDLINE | ID: mdl-12781360
Adoptive T cell immunotherapy is an evolving technology with the potential of providing a means to safely and effectively target tumor cells for destruction.
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Database: MEDLINE Main subject: T-Lymphocytes / Immunotherapy, Adoptive / Neoplasms Limits: Animals / Humans Language: En Journal: Cancer Cell Journal subject: NEOPLASIAS Year: 2003 Type: Article Affiliation country: United States
Search on Google
Add to My VHL
Print
XML
PubMed Links

Database: MEDLINE Main subject: T-Lymphocytes / Immunotherapy, Adoptive / Neoplasms Limits: Animals / Humans Language: En Journal: Cancer Cell Journal subject: NEOPLASIAS Year: 2003 Type: Article Affiliation country: United States